INGA LEVERETT: Open Payments
NPI 1336526292 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 33 payments from 8 companies in 2025. Trend: 2023 $53 · 2024 $575 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 10 | $150 |
| Indivior Inc. | 10 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $121 |
| Neurocrine BioSciences, Inc. | 2 | $59 |
| Alkermes, Inc. | 2 | $58 |
| ABBVIE INC. | 2 | $49 |
| Orexo US, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: BRIXADI, SUBLOCADE, CAPLYTA, INGREZZA, VIVITROL, MAVYRET, Zubsolv, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
